Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer feels invulnerable

Executive Summary

Pfizer shareholders approve motion to replace current "classified" board structure (directors serving staggered three-year terms) with annual election of all directors April 24. Pfizer CEO Henry McKinnell explains that annual election of all directors is in keeping with the principle that "directors should be responsive to the shareholder group. If the directors do something the shareholders don't like, the shareholders should be able to kick us bums out, quite frankly." The classified board structure was set up by Pfizer decades ago to provide a degree of protection against hostile takeovers, McKinnell notes, to head off the possibility that a competing board "might be nominated and elected by the opposing company." However, "in this present day and age, as the third most valuable company in the world, there quite frankly is nobody who could launch a hostile takeover bid against Pfizer"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS041708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel